Nordhealth AS (NORDH.OL) Stock Analysis & Winston Score
Nordhealth AS is a Nordic software company that builds digital tools for healthcare providers. Its main products are practice management and clinical software platforms used by veterinary clinics and human healthcare clinics — helping staff book appointments, manage patient records, and handle billing. The company operates primarily across the Nordic countries, with a growing presence in other European markets. Nordhealth makes money by charging clinics recurring subscription fees for its software, which creates a relatively predictable revenue stream. With a gross margin near 60%, the underlying software business is reasonably profitable at the product level, but the company is still spending heavily on growth, resulting in significant operating losses. Its competitive position relies on deep integration into clinic workflows, which makes switching to a rival system costly and disruptive for customers — a common moat in vertical software. The key risk is that reaching profitability depends on growing its customer base fast enough to cover its high operating costs, and competition from larger health-tech players could slow that progress.
Winston Score: 15/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
